Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.

The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech and ProQR Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy).

Report Scope

The Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Report

Report Metric	Details
Report Name	Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market
Segment by Type	Dominant Optic Atrophy Recessive Optic Atrophy
Segment by Application	Hospitals Eye Clinics Medical Research Institute Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics, Sanofi, Spark Therapeutics, Stealth BioTherapeutics, Usher Syndrome
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report?

Ans: The main players in the Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market are Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech, ProQR Therapeutics, Sanofi, Spark Therapeutics, Stealth BioTherapeutics, Usher Syndrome

What are the Application segmentation covered in the Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report?

Ans: The Applications covered in the Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report are Hospitals, Eye Clinics, Medical Research Institute, Other

What are the Type segmentation covered in the Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report?

Ans: The Types covered in the Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market report are Dominant Optic Atrophy, Recessive Optic Atrophy

1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Overview

1.1 Product Overview and Scope of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)

1.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Type

1.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Type (2024-2030)

1.2.2 Dominant Optic Atrophy

1.2.3 Recessive Optic Atrophy

1.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Segment by Application

1.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Eye Clinics

1.3.4 Medical Research Institute

1.3.5 Other

1.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size Estimates and Forecasts

1.4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue 2019-2030

1.4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales 2019-2030

1.4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competition by Manufacturers

2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2019-2024)

2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price by Manufacturers (2019-2024)

2.4 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Type & Application

2.7 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation and Trends

2.7.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players Market Share by Revenue

2.7.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Retrospective Market Scenario by Region

3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2019-2030

3.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2019-2024

3.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region: 2025-2030

3.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019-2030

3.3.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019-2024

3.3.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2025-2030

3.4 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country

3.4.1 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

3.4.3 North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country

3.5.1 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

3.5.3 Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country

3.6.1 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

3.6.3 Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country

3.7.1 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

3.7.3 Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Facts & Figures by Country

3.8.1 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2030)

3.8.3 Middle East and Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2030)

4.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2019-2024)

4.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Type (2025-2030)

4.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2030)

4.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2030)

4.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2019-2024)

4.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Type (2025-2030)

4.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2030)

4.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Type (2019-2030)

5 Segment by Application

5.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2030)

5.1.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2019-2024)

5.1.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Application (2025-2030)

5.1.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2030)

5.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2030)

5.2.1 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2019-2024)

5.2.2 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Application (2025-2030)

5.2.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2030)

5.3 Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Alkeus Pharmaceuticals

6.1.1 Alkeus Pharmaceuticals Corporation Information

6.1.2 Alkeus Pharmaceuticals Description and Business Overview

6.1.3 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.1.5 Alkeus Pharmaceuticals Recent Developments/Updates

6.2 Amgen

6.2.1 Amgen Corporation Information

6.2.2 Amgen Description and Business Overview

6.2.3 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.2.5 Amgen Recent Developments/Updates

6.3 Biovista

6.3.1 Biovista Corporation Information

6.3.2 Biovista Description and Business Overview

6.3.3 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.3.5 Biovista Recent Developments/Updates

6.4 Editas Medicine

6.4.1 Editas Medicine Corporation Information

6.4.2 Editas Medicine Description and Business Overview

6.4.3 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.4.5 Editas Medicine Recent Developments/Updates

6.5 GenSight Biologics

6.5.1 GenSight Biologics Corporation Information

6.5.2 GenSight Biologics Description and Business Overview

6.5.3 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.5.5 GenSight Biologics Recent Developments/Updates

6.6 Ixchel Pharma

6.6.1 Ixchel Pharma Corporation Information

6.6.2 Ixchel Pharma Description and Business Overview

6.6.3 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.6.5 Ixchel Pharma Recent Developments/Updates

6.7 Khondrion

6.6.1 Khondrion Corporation Information

6.6.2 Khondrion Description and Business Overview

6.6.3 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.7.5 Khondrion Recent Developments/Updates

6.8 Mitotech

6.8.1 Mitotech Corporation Information

6.8.2 Mitotech Description and Business Overview

6.8.3 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.8.5 Mitotech Recent Developments/Updates

6.9 ProQR Therapeutics

6.9.1 ProQR Therapeutics Corporation Information

6.9.2 ProQR Therapeutics Description and Business Overview

6.9.3 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.9.4 ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.9.5 ProQR Therapeutics Recent Developments/Updates

6.10 Sanofi

6.10.1 Sanofi Corporation Information

6.10.2 Sanofi Description and Business Overview

6.10.3 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.10.5 Sanofi Recent Developments/Updates

6.11 Spark Therapeutics

6.11.1 Spark Therapeutics Corporation Information

6.11.2 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview

6.11.3 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.11.5 Spark Therapeutics Recent Developments/Updates

6.12 Stealth BioTherapeutics

6.12.1 Stealth BioTherapeutics Corporation Information

6.12.2 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview

6.12.3 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.12.5 Stealth BioTherapeutics Recent Developments/Updates

6.13 Usher Syndrome

6.13.1 Usher Syndrome Corporation Information

6.13.2 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Description and Business Overview

6.13.3 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product Portfolio

6.13.5 Usher Syndrome Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Chain Analysis

7.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Mode & Process

7.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales and Marketing

7.4.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Channels

7.4.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors

7.5 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers

8 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Dynamics

8.1 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Industry Trends

8.2 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers

8.3 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges

8.4 Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Alkeus Pharmaceuticals

Stealth Biotherapeutics

Usher Syndrome

List of Tables

Table 1. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Competitive Situation by Manufacturers in 2023

Table 4. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) of Key Manufacturers (2019-2024)

Table 5. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (USD/Piece) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Product Type & Application

Table 12. Global Key Manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy), Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)

Table 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2024)

Table 19. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)

Table 20. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2025-2030)

Table 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2024)

Table 23. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2025-2030)

Table 25. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 27. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 28. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 32. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 33. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2019-2024) & (K Pcs)

Table 37. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Region (2025-2030) & (K Pcs)

Table 38. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 42. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 43. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2019-2024) & (K Pcs)

Table 47. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales by Country (2025-2030) & (K Pcs)

Table 48. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2019-2024)

Table 51. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Type (2025-2030)

Table 52. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2019-2024)

Table 53. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Type (2025-2030)

Table 54. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2019-2024)

Table 57. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Type (2025-2030)

Table 58. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2019-2024)

Table 59. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2025-2030)

Table 60. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Application (2019-2024)

Table 61. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs) by Application (2025-2030)

Table 62. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2019-2024)

Table 63. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Application (2025-2030)

Table 64. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2019-2024)

Table 67. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Application (2025-2030)

Table 68. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2019-2024)

Table 69. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2025-2030)

Table 70. Alkeus Pharmaceuticals Corporation Information

Table 71. Alkeus Pharmaceuticals Description and Business Overview

Table 72. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 73. Alkeus Pharmaceuticals Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 74. Alkeus Pharmaceuticals Recent Developments/Updates

Table 75. Amgen Corporation Information

Table 76. Amgen Description and Business Overview

Table 77. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 78. Amgen Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 79. Amgen Recent Developments/Updates

Table 80. Biovista Corporation Information

Table 81. Biovista Description and Business Overview

Table 82. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 83. Biovista Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 84. Biovista Recent Developments/Updates

Table 85. Editas Medicine Corporation Information

Table 86. Editas Medicine Description and Business Overview

Table 87. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 88. Editas Medicine Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 89. Editas Medicine Recent Developments/Updates

Table 90. GenSight Biologics Corporation Information

Table 91. GenSight Biologics Description and Business Overview

Table 92. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 93. GenSight Biologics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 94. GenSight Biologics Recent Developments/Updates

Table 95. Ixchel Pharma Corporation Information

Table 96. Ixchel Pharma Description and Business Overview

Table 97. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 98. Ixchel Pharma Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 99. Ixchel Pharma Recent Developments/Updates

Table 100. Khondrion Corporation Information

Table 101. Khondrion Description and Business Overview

Table 102. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 103. Khondrion Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 104. Khondrion Recent Developments/Updates

Table 105. Mitotech Corporation Information

Table 106. Mitotech Description and Business Overview

Table 107. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 108. Mitotech Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 109. Mitotech Recent Developments/Updates

Table 110. ProQR Therapeutics Corporation Information

Table 111. ProQR Therapeutics Description and Business Overview

Table 112. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 113. ProQR Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 114. ProQR Therapeutics Recent Developments/Updates

Table 115. Sanofi Corporation Information

Table 116. Sanofi Description and Business Overview

Table 117. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 118. Sanofi Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 119. Sanofi Recent Developments/Updates

Table 120. Spark Therapeutics Corporation Information

Table 121. Spark Therapeutics Description and Business Overview

Table 122. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 123. Spark Therapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 124. Spark Therapeutics Recent Developments/Updates

Table 125. Stealth BioTherapeutics Corporation Information

Table 126. Stealth BioTherapeutics Description and Business Overview

Table 127. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 128. Stealth BioTherapeutics Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 129. Stealth BioTherapeutics Recent Developments/Updates

Table 130. Usher Syndrome Corporation Information

Table 131. Usher Syndrome Description and Business Overview

Table 132. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (K Pcs), Revenue (US$ Million), Price (USD/Piece) and Gross Margin (2019-2024)

Table 133. Usher Syndrome Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Product

Table 134. Usher Syndrome Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Distributors List

Table 138. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Customers List

Table 139. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Trends

Table 140. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Drivers

Table 141. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Challenges

Table 142. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy)

Figure 2. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Type in 2023 & 2030

Figure 4. Dominant Optic Atrophy Product Picture

Figure 5. Recessive Optic Atrophy Product Picture

Figure 6. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Application in 2023 & 2030

Figure 8. Hospitals

Figure 9. Eye Clinics

Figure 10. Medical Research Institute

Figure 11. Other

Figure 12. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size (2019-2030) & (US$ Million)

Figure 14. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales (2019-2030) & (K Pcs)

Figure 15. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Average Price (USD/Piece) & (2019-2030)

Figure 16. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Report Years Considered

Figure 17. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Share by Manufacturers in 2023

Figure 18. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Players: Market Share by Revenue in 2023

Figure 20. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2019-2030)

Figure 23. North America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2019-2030)

Figure 27. Europe Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2019-2030)

Figure 28. Germany Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Region (2019-2030)

Figure 35. China Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2019-2030)

Figure 46. Latin America Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2019-2030)

Figure 56. Global Revenue Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Type (2019-2030)

Figure 57. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Type (2019-2030)

Figure 58. Global Sales Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2019-2030)

Figure 59. Global Revenue Market Share of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) by Application (2019-2030)

Figure 60. Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Price (USD/Piece) by Application (2019-2030)

Figure 61. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Value Chain

Figure 62. Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions